The Grants and Contracts Office (GCO) offers the following reminders about guidelines, updates, and policies pertaining to National Institutes of Health (NIH) grants and their administration.
Option to Report Preprints and Other Interim Research Products Effective 5/25/17 (NOT-OD-17-050)
(excerpted from NIH Notice)
Interim Research Products are complete, public research products that are not final. A common form is the preprint, which is a complete and public draft of a scientific document. Preprints are typically unreviewed manuscripts written in the style of a peer-reviewed journal article. Scientists issue preprints to speed dissemination, establish priority, obtain feedback, and offset publication bias. Another common type of interim product is a preregistered protocol, where a scientist publicly declares key elements of their research protocol in advance. Preregistration can help scientists enhance the rigor of their work.
For applications submitted for the May 25, 2017 due date and thereafter, awardees can claim these products on their progress report publication list. They can also report them on their RPPR as of May 25, 2017, and link them to their award in their My Bibliography account.
For complete information, please read NOT-OD-17-050.
Appendix Policy Change for NIH/AHRQ/NIOSH Applications Submitted for Due Dates On or After 1/25/17 (NOT-OD-17-035)
Updated Font Guidelines for Applications to Due Dates On or After 1/25/17 (NOT-OD-17-030)
Coming Down the Pike – Form Changes Affecting 1/25/18 Competitive Grant Applications and Beyond (NOT-OD-17-062)
The NIH is announcing application form changes planned for competitive applications due 1/25/18 and beyond. The form changes center on consolidating human subject and clinical trial information. Please read NOT-OD-17-062 for more information about the move form the current FORMS-D to a FORMS-E version.
Please contact Allison Gottlieb, Director, Sponsored Programs Education, GCO, if you have any questions or need additional information.